AN2 Therapeutics, Inc.: shareholders and insiders

ANTXNASDAQHealthcare · Pharmaceutical Preparations

Price

$5.08

November 20, 2026Market cap $193M

What Ploutos Investor adds for AN2 Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 5 fiscal years, from 2021
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 27% since Nov 9, 2026, when the 10-Q these figures come from was filed ($4.00 then, $5.08 on Nov 20, 2026). The figures date from before that move.10-Q

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Reading the newest filings from the SEC. This part fills in on its own in a few seconds.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

6 Holders over 5%May 15, 2026 Latest filing
  • Commodore Capital LPwith 3 more persons
    Share of class9.90%
  • Coastlands Capital LPwith 4 more persons
    Share of class9.30%
  • Vivo Opportunity Fund Holdings, L.P.with 3 more persons
    Share of class8.00%
  • Adjuvant Global Health Technology Fund, L.P.with 3 more persons
    Share of class7.90%
  • Eric Easom
    Share of class7.90%
  • Integrated Core Strategies (US) LLCwith 3 more persons
    Share of class6.30%
Fell to 5% or less (6)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Almitas Capital LLC4.10%May 15, 202613G/A
  • BML Investment Partners, L.P.13D1.40%Jun 18, 202513D/A
  • TCG Crossover GP I, LLC0.00%Feb 14, 202513G/A
  • Brii Biosciences Limited3.10%Feb 14, 202513G/A
  • Frazier Life Sciences Public Fund, L.P.0.00%Feb 14, 202513G/A
  • RA Capital Management, L.P.0.00%Feb 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Millennium Mgmt (Englander)
    In the quarter+6.8%
  • Citadel Advisors (Griffin)
    In the quarter+3.4%
  • Renaissance Technologies
    In the quarter-38%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 7.61% of its shares outstanding were held short, +15.9% since the report before.

Shares held short
2.89M
7.61%
Since the report before2.49M on Sep 30, 2026
+15.9%
7.4
390.8K
More days to cover thanof 4,578 US-listed companies with enough volume
80%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 255.8K
  • Nov 15, 2023: Shares held short 319.0K
  • Nov 30, 2023: Shares held short 282.1K
  • Dec 15, 2023: Shares held short 166.6K
  • Dec 29, 2023: Shares held short 294.4K
  • Jan 12, 2024: Shares held short 302.1K
  • Jan 31, 2024: Shares held short 280.3K
  • Feb 15, 2024: Shares held short 336.2K
  • Feb 29, 2024: Shares held short 295.3K
  • Mar 15, 2024: Shares held short 319.4K
  • Mar 28, 2024: Shares held short 272.5K
  • Apr 15, 2024: Shares held short 460.5K
  • Apr 30, 2024: Shares held short 736.9K
  • May 15, 2024: Shares held short 693.8K
  • May 31, 2024: Shares held short 746.9K
  • Jun 14, 2024: Shares held short 707.3K
  • Jun 28, 2024: Shares held short 677.0K
  • Jul 15, 2024: Shares held short 690.7K
  • Jul 31, 2024: Shares held short 683.4K
  • Aug 15, 2024: Shares held short 386.8K
  • Aug 30, 2024: Shares held short 146.9K
  • Sep 13, 2024: Shares held short 249.6K
  • Sep 30, 2024: Shares held short 188.5K
  • Oct 15, 2024: Shares held short 139.1K
  • Oct 31, 2024: Shares held short 133.6K
  • Nov 15, 2024: Shares held short 379.6K
  • Nov 29, 2024: Shares held short 71.4K
  • Dec 13, 2024: Shares held short 74.1K
  • Dec 31, 2024: Shares held short 90.0K
  • Jan 15, 2025: Shares held short 78.6K
  • Jan 31, 2025: Shares held short 58.8K
  • Feb 14, 2025: Shares held short 78.6K
  • Feb 28, 2025: Shares held short 112.0K
  • Mar 14, 2025: Shares held short 71.2K
  • Mar 31, 2025: Shares held short 61.2K
  • Apr 15, 2025: Shares held short 82.3K
  • Apr 30, 2025: Shares held short 36.1K
  • May 15, 2025: Shares held short 42.4K
  • May 30, 2025: Shares held short 33.2K
  • Jun 13, 2025: Shares held short 52.5K
  • Jun 30, 2025: Shares held short 34.5K
  • Jul 15, 2025: Shares held short 33.2K
  • Jul 31, 2025: Shares held short 14.4K
  • Aug 15, 2025: Shares held short 15.2K
  • Aug 29, 2025: Shares held short 30.5K
  • Sep 15, 2025: Shares held short 58.8K
  • Sep 30, 2025: Shares held short 67.9K
  • Oct 15, 2025: Shares held short 40.7K
  • Oct 31, 2025: Shares held short 38.1K
  • Nov 14, 2025: Shares held short 47.5K
  • Nov 28, 2025: Shares held short 37.6K
  • Dec 15, 2025: Shares held short 41.4K
  • Dec 31, 2025: Shares held short 44.9K
  • Jan 15, 2026: Shares held short 50.0K
  • Jan 30, 2026: Shares held short 52.6K
  • Feb 13, 2026: Shares held short 53.1K
  • Feb 27, 2026: Shares held short 58.2K
  • Mar 13, 2026: Shares held short 711.6K
  • Mar 31, 2026: Shares held short 564.3K
  • Apr 15, 2026: Shares held short 633.9K
  • Apr 30, 2026: Shares held short 879.5K
  • May 15, 2026: Shares held short 836.4K
  • May 29, 2026: Shares held short 1.21M
  • Jun 15, 2026: Shares held short 1.31M
  • Jun 30, 2026: Shares held short 1.92M
  • Jul 15, 2026: Shares held short 2.44M
  • Jul 31, 2026: Shares held short 2.38M
  • Aug 14, 2026: Shares held short 2.22M
  • Aug 31, 2026: Shares held short 2.51M
  • Sep 15, 2026: Shares held short 2.40M
  • Sep 30, 2026: Shares held short 2.49M
  • Oct 15, 2026: Shares held short 2.89M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading70.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 70.7% of the shares in the reported trades were short sales, against 54.6% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
70.7%
The 14 beforeOct 14, 2026 – Nov 2, 2026
54.6%
Change
+16.1 pts
Short sales a dayon average, of 132.1K shares
93.4K
More than atof 3,666 US-listed companies, same days
98%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 67.1%
  • Oct 15, 2026: Short sales 43.2%
  • Oct 16, 2026: Short sales 67.4%
  • Oct 19, 2026: Short sales 82.8%
  • Oct 20, 2026: Short sales 88.3%
  • Oct 21, 2026: Short sales 87.5%
  • Oct 22, 2026: Short sales 56.1%
  • Oct 23, 2026: Short sales 63.5%
  • Oct 26, 2026: Short sales 75.5%
  • Oct 27, 2026: Short sales 30.7%
  • Oct 28, 2026: Short sales 34.3%
  • Oct 29, 2026: Short sales 48.5%
  • Oct 30, 2026: Short sales 43.8%
  • Nov 2, 2026: Short sales 42%
  • Nov 3, 2026: Short sales 59.5%
  • Nov 4, 2026: Short sales 72.8%
  • Nov 5, 2026: Short sales 48.9%
  • Nov 6, 2026: Short sales 90.2%
  • Nov 9, 2026: Short sales 91.4%
  • Nov 10, 2026: Short sales 88.2%
  • Nov 11, 2026: Short sales 53.1%
  • Nov 12, 2026: Short sales 87.5%
  • Nov 13, 2026: Short sales 84.4%
  • Nov 16, 2026: Short sales 78.2%
  • Nov 17, 2026: Short sales 72.9%
  • Nov 18, 2026: Short sales 50.7%
  • Nov 19, 2026: Short sales 68%
  • Nov 20, 2026: Short sales 70.4%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

8 ETFs holding it0.03% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.03%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.00%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.00%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

8 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

67 Managers, Q2 2026$119M Value of their positions
  • Q3 2025: Managers 36
  • Q4 2025: Managers 38
  • Q1 2026: Managers 54
  • Q2 2026: Managers 67

Institutional investors by quarter

The fund managers holding ANTX, quarter by quarter, from Q2 2015 to Q2 2025, 41 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 67 managers held 24.58M shares, worth $119M. During the quarter 27 opened a position, 15 closed one, 14 added and 14 trimmed.

The largest holders, Q2 2026

  • Vivo Capital
    In the quarter
  • Commodore Capital
    In the quarter+26%
  • Millennium Mgmt (Englander)
    In the quarter+4.3%
  • BlackRock
    In the quarter+422%
  • Spruce Street Capital
    In the quarter
  • Almitas Capital
    In the quarter-0.7%
  • Vanguard Capital Management
    In the quarter+23%
  • Adage Capital Partners Gp
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+513%
  • Boxer Capital Management
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do AN2 Therapeutics's filings show?

Who buys and sells is one part of AN2 Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ANTX's shareholders

Didn't find what you were looking for?

Ask us
Which well-known managers hold ANTX?

3 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $13M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.